LASE Prices $7.9M Public Offering at $0.75, Deeply Dilutive and Below Previous Offering Price

What happened

Laser Photonics announced pricing of a $7.9M public offering of 10.5M shares plus Series B-1 and B-2 warrants at a combined $0.75 per share, significantly below its recent closing price near $1.65 and even below the report's attractive entry of $1.00. This is the second deeply discounted offering in recent months (Feb 2026 at $0.70) and confirms ongoing reliance on equity financing amid persistent cash burn, as Q1'26 operating cash outflow was $(1.84)M. The inclusion of two warrant series exercisable at $0.75 creates substantial overhang and potential additional dilution if exercised. This offering directly triggers the report's 'Decreases If' condition: another discounted equity offering within two quarters while operating cash burn stays above $1.5M. The new capital likely funds only about four quarters of current burn, making further raises likely unless operational performance improves markedly.

Implication

The $0.75 pricing signals severe financing stress and validates the bear case's premise of serial deeply discounted offerings. With 10.5M new shares plus warrants, existing holders face immediate dilution, and the stock may trade down toward the offering price. The $7.9M raise, at Q1'26 burn of $1.84M/quarter, provides only about four quarters of runway, so another raise may be needed if revenues do not recover. The bear scenario (35% probability, $0.90 implied value) now looks more likely, and even the base case ($1.70) seems optimistic given the financing terms. We suggest staying on the sidelines until we see either a named, funded defense milestone or two consecutive quarters of positive gross profit and reduced cash burn.

Thesis delta

The previous WAIT rating with an attractive entry of $1.00 is now undermined by the $0.75 offering price, which is below that threshold. The bear case probability should increase from 35% to at least 45%, and the base case probability decrease correspondingly. The implied fair value shifts toward the bear case of $0.90 or lower, and the key positive catalysts (defense funding or gross profit recovery) must now overcome the dilution overhang. We maintain a WAIT rating but with a stronger negative bias and reduced conviction.